PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.40
+1.05%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- $21.5M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.26
- Revenue actual
- $22.4M
- Revenue estimate
- $16.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.6%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $16
- PT range
- $13 – $17
- Analysts
- 4
1 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.26 | -$0.30 | Miss -13.93% | $22.4M |
| May 7, 2026 | -$0.23 | -$0.29 | Miss -26.09% | $15.5M |
| Nov 4, 2025 | -$0.28 | -$0.24 | Beat 14.29% | $14.5M |
| Feb 27, 2025 | -$0.32 | -$0.23 | Beat 28.13% | $16.8M |
| Feb 28, 2024 | -$0.53 | -$0.46 | Beat 13.21% | $19.7M |
| May 3, 2023 | -$0.62 | -$0.61 | Beat 1.61% | $18.9M |
| Feb 23, 2023 | -$0.65 | -$0.67 | Miss -3.08% | $16.7M |
| Nov 2, 2022 | -$0.63 | -$0.58 | Beat 7.94% | $14.9M |
| Aug 3, 2022 | -$0.63 | -$0.60 | Beat 4.76% | $18.2M |
| May 4, 2022 | -$0.57 | -$0.63 | Miss -10.53% | $15.2M |
| Feb 24, 2022 | -$0.51 | -$0.45 | Beat 11.76% | $20.7M |
| Nov 4, 2021 | -$0.40 | -$0.40 | In line | $22.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026